Master css

Using Routine Cardiac MRI vs. Echocardiography (with Selective MRI) in Nonischemic Heart Failure

Viernes, Junio 5, 2020

Routine MRI doesn’t improve diagnostic specificity or patient outcomes.

Cardiac magnetic resonance (CMR) imaging is increasingly used to assess structure and function. In cardiomyopathy, CMR is used to assess patients for evidence of infiltration or inflammation; late gadolinium enhancement, a common finding in cardiomyopathies, has prognostic implications. These investigators assessed routine CMR versus echocardiography with selective use of CMR in patients with newly diagnosed or worsening heart failure (HF).

Código de aprobación: PP-CVP-ECU-0024

Todos los derechos reservados © 2019. Pfizer Cía. Ltda. La información contenida en este sitio web tiene exclusivamente propósitos académicos e informativos para profesionales de la salud en la República del Ecuador. Prohibida su reproducción total o parcial sin autorización de su titular.

Para mayor información comuníquese al Departamento Médico de Pfizer. E-mail: RSCLIM-INFOMEDPEB@pfizer.com

PP-GEP-ECU-0071

Master css

Using Routine Cardiac MRI vs. Echocardiography (with Selective MRI) in Nonischemic Heart Failure

{* message_signIn *}

{* message_welcomeBack *}

{* message_welcomeBack *}

{* message_registeringThankYou *}

{* message_emailPasswordResetInstructions *}

Master css

You are here

Educación Médica Relacionada

Using Routine Cardiac MRI vs. Echocardiography (with Selective MRI) in Nonischemic Heart Failure

Únicamente para profesionales de la salud

{* message_withExistingAccount *}

{* message_joinNow *}

{* message_signIn *}

{* message_welcomeBack *}

{* message_welcomeBack *}

{* message_registeringThankYou *}

{* message_emailPasswordResetInstructions *}